Dietary flavonoids induce MLL translocations in primary human CD34+ cells

Carcinogenesis

Volumn 28, Issue 8, 2007, Pages 1703-1709

  van Doorn Khosrovani, Sahar Barjesteh van Waalwijk ^a   Janssen, Jannie ^a   Maas, Lou M ^a   Godschalk, Roger W L ^a   Nijhuis, Jan G ^b   van Schooten, Frederik J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; ETOPOSIDE; FLAVONOID; GENISTEIN; HYDROQUINONE; KAEMPFEROL; MIXED LINEAGE LEUKEMIA PROTEIN; QUERCETIN;

ARTICLE; CANCER RISK; CD34 SELECTION; CHILDHOOD LEUKEMIA; CHROMOSOME TRANSLOCATION; COMET ASSAY; CONTROLLED STUDY; DIETARY INTAKE; DNA STRAND BREAKAGE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INVERSE POLYMERASE CHAIN REACTION; LEUKEMOGENESIS; MATERNAL NUTRITION; MONONUCLEAR CELL; MONOSOMY; NEWBORN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TOXICITY TESTING; TRISOMY;

ANTIGENS, CD34; CELLS, CULTURED; DIETARY SUPPLEMENTS; DNA BREAKS, DOUBLE-STRANDED; ETOPOSIDE; FLAVONOIDS; GENISTEIN; HUMANS; KAEMPFEROLS; LEUKEMIA; LEUKOCYTES, MONONUCLEAR; MYELOID-LYMPHOID LEUKEMIA PROTEIN; QUERCETIN; TRANSLOCATION, GENETIC;

EID: 34548099120     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm102     Document Type: Article

References (56)

1. Ford,A.M. et al. (1998) Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc. Natl Acad. Sci. USA, 95 4584-4588.
2. Ford,A.M. et al. (1993) In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature, 363 358-360.
3. Hess,J.L. et al. (1997) Defects in yolk sac hematopoiesis in Mll-null embryos. Blood, 90, 1799-1806.
4. Rowley,J.D. (1998) The critical role of chromosome translocations in human leukemias. Annu. Rev. Genet., 32, 495-519.
5. Ross,J.A. et al. (1994) Epidemiology of childhood leukemia, with a focus on infants. Epidemiol. Rev., 16, 243-272.
6. Canaani,E. et al. (1995) Molecular genetics of 11q23 chromosome translocations. Adv. Cancer Res., 66, 213-234.
7. Pui,C.H. et al. (1991) Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N. Engl. J. Med., 325, 1682-1687.
8. Kumar,L. (1993) Epipodophyllotoxins and secondary leukaemia. Lancet 342, 819-820.
9. Ross,J.A. et al. (1994) Infant leukemia, topoisomerase II inhibitors, and the MLL gene. J. Natl Cancer Inst., 86, 1678-1680.
10. Ross,J.A. (1998) Maternal diet and infant leukemia: A role for DNA topoisomerase II inhibitors? Int. J. Cancer, 11, 26-28.
11. Fortune,J.M. et al. (2000) Topoisomerase II as a target for anticancer drugs: When enzymes stop being nice. Prog. Nucleic Acid Res. Mol. Biol., 64, 221-253.
12. Berger,J.M. et al. (1996) Structure and mechanism of DNA topoisomerase II. Nature, 379, 225-232.
13. Suzuki,H. et al. (1995) Efficient induction of chromosome-type aberrations by topoisomerase II inhibitors closely associated with stabilization of the cleavable complex in cultured fibroblastic cells. Mutat. Res., 328, 151-161.
14. Blanco,J.G. et al. (2004) Etoposide induces chimeric Mll gene fusions. FASEB J., 18, 173-175.
15. Libura,J. et al. (2005) Therapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion. Blood, 105, 2124-2131.
16. Moneypenny,C.G. et al. (2006) MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells. Carcinogenesis, 27, 874-881.
17. Alexander,F.E. et al. (2001) Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res., 61 2542-2546.
18. Yamashita,Y. et al. (1990) Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem. Pharmacol., 39, 737-744.
19. Austin,C.A. et al. (1992) Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives. Biochem. J., 282, 83-89.
20. Constantinou,A. et al. (1995) Flavonoids as DNA topoisomerase antagonists and poisons: Structure-activity relationships. J. Nat. Prod., 58, 217-225.
21. Strick,R. et al. (2000) Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc. Natl Acad. Sci. USA, 97, 4790-4795.
22. Spector,L.G. et al. (2005) Maternal diet and infant leukemia: The DNA topoisomerase II inhibitor hypothesis: A report from the children's oncology group. Cancer Epidemiol. Biomarkers Prev., 14, 651-655.
23. Ross,J.A. et al. (1996) Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): A report from the Children's Cancer Group. Cancer Causes Control, 7, 581-590.
24. Hotfilder,M. et al. (2005) Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells. Cancer Res., 65, 1442-1449.
25. Munoz,L. et al. (2003) Acute myeloid leukemia with MLL rearrangements: Clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells. Leukemia, 17, 76-82.
26. Whitaker,S.J. (1992) DNA damage by drugs and radiation: What is important and how is it measured? Eur. J. Cancer, 28, 273-276.
27. Zhang,L. et al. (1998) Benzene metabolites induce the loss and long arm deletion of chromosomes 5 and 7 in human lymphocytes. Leuk. Res., 22, 105-113.
28. Stillman,W.S. et al. (1999) The benzene metabolites hydroquinone and catechol act in synergy to induce dose-dependent hypoploidy and -5q31 in a human cell line. Leuk Lymphoma, 35, 269-281.
29. Stillman,W.S. et al. (2000) The benzene metabolite, hydroquinone, selectively induces 5q31- and -7 in human CD34+CD19- bone marrow cells. Exp. Hematol., 28, 169-176.
30. Stillman,W.S. et al. (1997) The benzene metabolite, hydroquinone, induces dose-dependent hypoploidy in a human cell line. Leukemia, 11, 1540-1545.
31. Smith,M.T. et al. (2000) Hydroquinone a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34-positive blood progenitor cells. Carcinogenesis, 21, 1485-1490.
32. Gillert,E. et al. (1999) A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells. Oncogene, 18, 4663-4671.
33. Broeker,P.L. et al. (1996) Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment related acute myeloid leukemia: Correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood, 87, 1912-1922.
34. Richardson,C. et al. (2000) Frequent chromosomal translocations induced by DNA double-strand breaks. Nature, 405, 697-700.
35. Lee,D.Y. et al. (1993) A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell, 72, 73-84.
36. Wang,Z. et al. (2004) Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science, 304, 1164-1166.
37. Gu,Y. et al. (1996) Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island. Nat. Genet., 13, 109-113.
38. Gecz,J. et al. (1996) Identification of the gene FMR2, associated with FRAXE mental retardation. Nat. Genet., 13, 105-108.
39. Domer,P.H. et al. (1993) Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc. Natl Acad. Sci. USA, 90, 7884-7888.
40. von Bergh,A.R. et al. (2002) LAF4, an AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia. Genes Chromosomes Cancer, 35, 92-96.
41. Taki,T. et al. (1999) AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23). Proc. Natl Acad. Sci. USA, 96, 14535-14540.
42. Navarro-Peran,E. et al. (2005) The antifolate activity of tea catechins. Cancer Res., 65, 2059-2064.
43. Thompson,J.R. et al. (2001) Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: A case-control study. Lancet, 358, 1935-1940.
44. Wiemels,J.L. et al. (2001) Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc. Natl Acad. Sci. USA, 98, 4004-4009.
45. Elliott,B. et al. (2005) Chromosomal translocation mechanisms at intronic alu elements in mammalian cells. Mol. Cell, 17, 885-894.
46. Kolomietz,E. et al. (2002) The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in minors. Genes Chromosomes Cancer, 35, 97-112.
47. Schichman,S.A. et al. (1994) ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. Cancer Res., 54, 4277-4280.
48. Nakada,S. et al. (2006) Early G2/M checkpoint failure as a molecular mechanism underlying etoposide-induced chromosomal aberrations. J. Clin. Invest., 116, 80-89.
49. Betti,C.J. et al. (2001) Apoptotic triggers initiate translocations within the MLL gene involving the nonhomologous end joining repair system. Cancer Res., 61, 4550-4555.
50. Betti,C.J. et al. (2003) Apoptotic stimuli initiate MLL-AF9 translocations that are transcribed in cells capable of division. Cancer Res., 63, 1377-1381.
51. Janssen,K et al. (1998) Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: Results from an in vitro and a dietary supplement study. Am. J. Clin. Nutr., 67 255-262.
52. Todaka,E. et al. (2005) Fetal exposure to phytoestrogens-the difference in phytoestrogen status between mother and fetus. Environ. Res., 99, 195-203.
53. Zandvliet,D.W. et al. (1996) Analysis of foetal expression sites of human type II DNA topoisomerase alpha and beta mRNAs by in situ hybridisation. Biochim. Biophys. Acta, 1307, 239-247.
54. Hubbard,G.P. et al. (2004) Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J. Thromb. Haemost., 2 2138-2145.
55. Wang,H.K. (2000) The therapeutic potential of flavonoids. Expert Opin. Investig. Drugs, 9, 2103-2119.
56. Verschoyle,R.D. et al. (2006) Preliminary safety evaluation of the putative cancer chemopreventive agent tricin, a naturally occurring flavone. Cancer Chemother. Pharmacol., 57, 1-6.